The academic turned biopharma innovator

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with JaeB Kim, Managing Director at Samsung Biologics America. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with JaeB, covering: A year at one of the largest and fastest-growing CDMOs in the world. Growing a US presence within the thriving biopharma cluster in San Francisco Bay with ambitious plans for future expansion. The need for industry to ‘give’ in order to ‘take’ from innovation in academia, along with the pivotal role that collaboration has played during the pandemic. How Covid-19 has ‘tested the system’ from R&D to logistics and patient supply and how this will enable the sector to be better prepared for a more orchestrated response to future pandemics. JaeB is a senior life sciences professional with 15 years of experience in biotech and biologics manufacturing. With an MBA and a PhD in Cancer Biology, he worked for PerkinElmer before joining global CDMO giant Samsung Biologics in 2020. JaeB is also an Adjunct Assistant Professor at Michigan State University. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.